Lumida
/ICUI
⌘K
ICU Medical Inc

ICU Medical Inc

ICUI
$157.51USD-2.87%-4.66 today

MARKET CAP

3.9B

P/E (TTM)

19.7x

FWD P/E

18.0x

DAY RANGE

$157 – $163

52W RANGE

$107
$163

AI Summary

Stalk
Buy NowHigh

In a Stage 2 Advancing corrective reset that has resumed its upcycle, ICUI is pulling back into its rising EMAs, offering a tactical entry ahead of continuation. The active Lockout Rally pattern signals strong demand fueled by short covering and positioning asymmetry. EMAs remain stacked and rising, and no exhaustion is evident despite overbought context. Key risks include a failure to hold the short-term EMAs and resistance at recent highs that could stall the advance.

  • Q1 revenue $526M with 1% organic growth despite deconsolidation headwinds.
  • FY2026 free cash flow guidance of ~$150M underscores strong cash generation.
  • Tariffs expected to add $25–30M in FY25 expenses, squeezing gross margins.
Full analysis →
Insider Trades65 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 22, 2026SellICUIDaniel WoolsonPresident2,123$132.21$3.9B-3.28%+47.21%$280.7K-8.63%Buy Now
May 14, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel2,447$124.08$3.9B-3.28%+47.21%$303.6K-11.17%Buy Now
Mar 15, 2026SellICUIBen SousaChief Information Officer718$125.85$3.9B-3.28%+47.21%$90.4K-11.88%Buy Now
Mar 15, 2026SellICUIDaniel WoolsonVP, GM-Infusion Capital1,295$125.85$3.9B-3.28%+47.21%$163.0K-5.00%Buy Now
Mar 15, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel4,047$125.85$3.9B-3.28%+47.21%$509.3K-8.59%Buy Now
Mar 15, 2026SellICUIBrian Michael BonnellChief Financial Officer7,595$125.85$3.9B-3.28%+47.21%$955.8K-5.08%Buy Now
Mar 15, 2026SellICUIChristian B. VoigtlanderChief Operating Officer8,096$125.85$3.9B-3.28%+47.21%$1.0M-8.16%Buy Now
Mar 15, 2026SellICUIVivek JainChairman and CEO12,145$125.85$3.9B-3.28%+47.21%$1.5M-4.61%Buy Now
Mar 7, 2026SellICUIBen SousaChief Information Officer5,278$132.00$3.9B-3.28%+47.21%$696.7K-22.04%Buy Now
Mar 7, 2026SellICUIDaniel WoolsonVP, GM-Infusion Capital8,209$132.00$3.9B-3.28%+47.21%$1.1M-10.96%Buy Now
Mar 7, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel16,280$132.00$3.9B-3.28%+47.21%$2.1M-20.98%Buy Now
Mar 7, 2026SellICUIBrian Michael BonnellChief Financial Officer40,930$127.93$3.9B-3.28%+47.21%$5.2M-28.17%Buy Now
Mar 7, 2026SellICUIChristian B. VoigtlanderChief Operating Officer41,613$132.00$3.9B-3.28%+47.21%$5.5M-43.31%Buy Now
Mar 7, 2026SellICUIVivek JainChairman and CEO62,419$125.83$3.9B-3.28%+47.21%$7.9M-24.11%Buy Now
Nov 25, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital2,897$152.35$3.9B-3.28%+47.21%$441.4K-20.41%Buy Now
Nov 11, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel930$142.34$3.9B-3.28%+47.21%$132.4K-14.56%Buy Now
Sep 12, 2025SellICUIVivek JainChairman and CEO127,282$130.38$3.9B-3.28%+47.21%$16.6M+0.00%Buy Now
Aug 14, 2025BuyICUIVivek JainChairman and CEO21,929$112.84$3.9B-3.28%+47.21%$2.5M+10.02%Buy Now
May 30, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel700$133.62$3.9B-3.28%+47.21%$93.5K-9.88%Buy Now
May 27, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer21,045$112.36$3.9B-3.28%+47.21%$2.4M+3.16%Buy Now
May 22, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer21,028$112.48$3.9B-3.28%+47.21%$2.4M+2.17%Buy Now
May 20, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer20,898$114.73$3.9B-3.28%+47.21%$2.4M+1.84%Buy Now
May 16, 2025SellICUIChristian B. VoigtlanderChief Operating Officer22,220$117.92$3.9B-3.28%+47.21%$2.6M+0.00%Buy Now
May 15, 2025SellICUIBen SousaChief Information Officer2,000$137.36$3.9B-3.28%+47.21%$274.7K-80.68%Buy Now
May 14, 2025SellICUIChristian B. VoigtlanderChief Operating Officer22,222$116.96$3.9B-3.28%+47.21%$2.6M+0.00%Buy Now
Mar 15, 2025SellICUIBen SousaChief Information Officer716$143.45$3.9B-3.28%+47.21%$102.7K-15.93%Buy Now
Mar 15, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel898$143.45$3.9B-3.28%+47.21%$128.8K-9.35%Buy Now
Mar 15, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital1,294$143.45$3.9B-3.28%+47.21%$185.6K-7.03%Buy Now
Mar 15, 2025SellICUIChristian B. VoigtlanderChief Operating Officer1,792$143.45$3.9B-3.28%+47.21%$257.1K-24.12%Buy Now
Mar 15, 2025SellICUIVivek JainChairman and CEO2,688$143.45$3.9B-3.28%+47.21%$385.6K-2.32%Buy Now
Mar 7, 2025SellICUIBen SousaChief Information Officer810$141.97$3.9B-3.28%+47.21%$115.0K-4.65%Buy Now
Mar 7, 2025SellICUIChristian B. VoigtlanderChief Operating Officer1,213$141.97$3.9B-3.28%+47.21%$172.2K-9.54%Buy Now
Mar 7, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital1,420$141.97$3.9B-3.28%+47.21%$201.6K-3.11%Buy Now
Mar 7, 2025SellICUIVivek JainChairman and CEO1,775$141.97$3.9B-3.28%+47.21%$252.0K-1.70%Buy Now
Mar 7, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel2,384$141.97$3.9B-3.28%+47.21%$338.5K-5.45%Buy Now
Jan 2, 2025SellICUIVivek JainChairman and CEO2,746$122.12$3.9B-3.28%+47.21%$335.3K+0.00%Buy Now
Dec 6, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital2,241$156.25$3.9B-3.28%+47.21%$350.2K-17.10%Buy Now
Dec 2, 2024SellICUIVivek JainChairman and CEO24,000$125.84$3.9B-3.28%+47.21%$3.0M+0.00%Buy Now
Nov 27, 2024SellICUIChristian B. VoigtlanderChief Operating Officer2,860$127.41$3.9B-3.28%+47.21%$364.4K+0.00%Buy Now
Nov 25, 2024SellICUIChristian B. VoigtlanderChief Operating Officer19,362$128.98$3.9B-3.28%+47.21%$2.5M+0.00%Buy Now
Nov 1, 2024SellICUIVivek JainChairman and CEO24,000$130.30$3.9B-3.28%+47.21%$3.1M+0.00%Buy Now
Oct 1, 2024SellICUIVivek JainChairman and CEO24,000$133.61$3.9B-3.28%+47.21%$3.2M+0.00%Buy Now
Sep 3, 2024SellICUIVivek JainChairman and CEO24,000$126.11$3.9B-3.28%+47.21%$3.0M+0.00%Buy Now
Aug 30, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital2,502$163.22$3.9B-3.28%+47.21%$408.4K-16.03%Buy Now
Aug 16, 2024SellICUIVivek JainChairman and CEO24,000$122.40$3.9B-3.28%+47.21%$2.9M+0.00%Buy Now
Aug 8, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel2,050$144.11$3.9B-3.28%+47.21%$295.4K-31.38%10b5-1Buy Now
May 30, 2024SellICUIChristian B. VoigtlanderChief Operating Officer12,539$103.95$3.9B-3.28%+47.21%$1.3M-86.05%Buy Now
May 10, 2024SellICUIBen SousaChief Information Officer2,000$105.55$3.9B-3.28%+47.21%$211.1K-60.26%Buy Now
Mar 15, 2024SellICUIBen SousaChief Information Officer463$98.08$3.9B-3.28%+47.21%$45.4K-7.26%Buy Now
Mar 15, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital791$98.27$3.9B-3.28%+47.21%$77.7K-5.36%Buy Now
Mar 15, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel890$98.08$3.9B-3.28%+47.21%$87.3K-8.34%Buy Now
Mar 15, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital1,294$98.08$3.9B-3.28%+47.21%$126.9K-5.69%Buy Now
Mar 15, 2024SellICUIBrian Michael BonnellChief Financial Officer1,780$98.08$3.9B-3.28%+47.21%$174.6K-5.36%Buy Now
Mar 15, 2024SellICUIChristian B. VoigtlanderChief Operating Officer1,780$98.08$3.9B-3.28%+47.21%$174.6K-8.55%Buy Now
Mar 15, 2024SellICUIVivek JainChairman and CEO2,671$98.08$3.9B-3.28%+47.21%$262.0K-2.28%Buy Now
Mar 7, 2024SellICUIBen SousaChief Information Officer1,317$105.23$3.9B-3.28%+47.21%$138.6K-13.80%Buy Now
Mar 7, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital3,884$105.19$3.9B-3.28%+47.21%$408.6K-7.75%Buy Now
Mar 7, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel8,662$104.95$3.9B-3.28%+47.21%$909.1K-20.09%Buy Now
Mar 7, 2024SellICUIBrian Michael BonnellChief Financial Officer13,444$105.05$3.9B-3.28%+47.21%$1.4M-14.64%Buy Now
Mar 7, 2024SellICUIChristian B. VoigtlanderChief Operating Officer13,444$105.05$3.9B-3.28%+47.21%$1.4M-31.86%Buy Now
Mar 7, 2024SellICUIVivek JainChairman and CEO18,305$105.11$3.9B-3.28%+47.21%$1.9M-4.48%Buy Now
Mar 4, 2024SellICUIChristian B. VoigtlanderChief Operating Officer13,603$107.19$3.9B-3.28%+47.21%$1.5M-66.23%Buy Now
Feb 12, 2024BuyICUIVivek JainChairman and CEO332,393$75.12$3.9B-3.28%+47.21%$25.0M+24.32%Buy Now
Dec 1, 2023SellICUIDaniel WoolsonVP, GM-Infusion Capital1,729$88.03$3.9B-3.28%+47.21%$152.2K-14.90%Buy Now
Sep 8, 2023SellICUIChristian B. VoigtlanderChief Operating Officer6,850$129.04$3.9B-3.28%+47.21%$883.9K-19.72%Buy Now